Neurava Announces Strategic Additions to Board of Directors Medical Device Veteran Daniel Moore and Jed Kay, an Elevate Ventures Operating Partner, Bring Unmatched Expertise
LIVN Stock | USD 50.04 0.06 0.12% |
About 53% of LivaNova PLC's investors are presently thinking to get in. The analysis of overall sentiment of trading LivaNova PLC stock suggests that some investors are interested at this time. LivaNova PLC's investing sentiment overview a quick insight into current market opportunities from investing in LivaNova PLC. Many technical investors use LivaNova PLC stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
LivaNova |
Neurava, a pioneering medical device company at the forefront of epilepsy care and management, is excited to announce that Daniel Moore, former CEO of Cyberonics and former Chairman of the Board at LivaNova, will serve as an independent director on its Board of Directors. Additionally, Neurava welcomes John Kay, an Operating Partner from Elevate Ventures, to the Board.
Read at finance.yahoo.com
LivaNova PLC Current Investor Sentiment
Panic Vs Confidence
53
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use LivaNova PLC's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward LivaNova PLC.
News SentimentBullish | Hype SentimentBearish | Insider SentimentWaiting |
LivaNova PLC Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards LivaNova PLC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
LivaNova PLC Fundamental Analysis
We analyze LivaNova PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LivaNova PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LivaNova PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
LivaNova PLC is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
LivaNova PLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LivaNova PLC stock to make a market-neutral strategy. Peer analysis of LivaNova PLC could also be used in its relative valuation, which is a method of valuing LivaNova PLC by comparing valuation metrics with similar companies.
Peers
LivaNova PLC Related Equities
GKOS | Glaukos Corp | 4.77 | ||||
IRTC | IRhythm Technologies | 3.49 | ||||
ITGR | Integer Holdings | 0.70 | ||||
ATEC | Alphatec Holdings | 0.41 | ||||
KIDS | Orthopediatrics Corp | 0.22 | ||||
GMED | Globus Medical | 0.06 | ||||
OFIX | Orthofix Medical | 0.05 | ||||
BRKR | Bruker | 0.55 | ||||
FNA | Paragon 28 | 0.57 | ||||
CNMD | CONMED | 1.90 | ||||
SIBN | Si Bone | 2.61 | ||||
LUNG | Pulmonx Corp | 2.89 | ||||
NPCE | Neuropace | 3.74 |
Check out LivaNova PLC Hype Analysis, LivaNova PLC Correlation and LivaNova PLC Performance. To learn how to invest in LivaNova Stock, please use our How to Invest in LivaNova PLC guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LivaNova PLC. If investors know LivaNova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LivaNova PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 14 | Earnings Share 0.43 | Revenue Per Share 22.907 | Quarterly Revenue Growth 0.112 | Return On Assets 0.0434 |
The market value of LivaNova PLC is measured differently than its book value, which is the value of LivaNova that is recorded on the company's balance sheet. Investors also form their own opinion of LivaNova PLC's value that differs from its market value or its book value, called intrinsic value, which is LivaNova PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LivaNova PLC's market value can be influenced by many factors that don't directly affect LivaNova PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LivaNova PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if LivaNova PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LivaNova PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.